MedTrace Logo

Temperature-elevating Armbaths for Arterial Hypertension

NCT05928702 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-07-03

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to learn about the effect of a hydrotherapeutic approach - a temperature-elevating armbath - in people with arterial hypertention. The main question\[s\] it aims to answer are:

* Can this kind of hydrotherapy lower the blood pressure and therefore be an additional approach to medical treatment in arterial hypertension?
* Besides blood pressure regulation, does this intervention affect sleep quality when being performed at night time or does it affect overall quality of life?

Participants will be advised to perform a temperature-elevating armbath once a day for 30 minutes on at least 5 days per week over 8 weeks.

The comparison group will continue treatment as usual, like continue their medication. 24h blood pressure measurements will be performed at the beginning, after 8 weeks and after 6 months in both groups. The main goal is to evaluate whether the intervention group shows lower blood pressure levels after a certain time of treatment.

After 6 months (end of trial) the control group will be offered to learn the temperature elevating armbath as well.

Conditions

  • Arterial Hypertension

Interventions

PROCEDURE

temperature-elevating armbath

Hydrotherapeutic Approach

Sponsors & Collaborators

  • Karl and Veronica Carstens Foundation

    collaborator OTHER

  • Kliniken Essen-Mitte

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-23
Primary Completion
2023-12-23
Completion
2024-06-24

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05928702 on ClinicalTrials.gov